EnteroBiotix Completes Phase 2 TrIuMPH Patient Enrollment for EBX-102-02 in IBS Study
**EnteroBiotix, Ltd.**, a biotechnology firm at the clinical stage, specializing in advanced microbiome therapeutics, has announced the fulfillment of participant recruitment for their phase 2 TrIuMPH clinical trial. This study is evaluating the safety, tolerability, and effectiveness of EBX-102-02, their […]
EnteroBiotix Completes Phase 2 TrIuMPH Patient Enrollment for EBX-102-02 in IBS Study Read More »